Tag: selective internal radiation therapy
UK SIRT audit finds “significant” overall survival improvement in HCC
A UK multicentre audit of selective internal radiation therapy (SIRT) practice in hepatocellular carcinoma (HCC) patients has demonstrated that treatment has “markedly” increased following...
Versatility meets control with SIR-Spheres personalised Y90 radioembolization
This advertorial is sponsored by Sirtex Medical.
When performing liver-directed therapy, precise targeting of tumours is crucial to protect healthy liver tissue. Supporting a tailored...
Multidisciplinary panel supports the positive role of SIRT at SUMM90YT conference
This advertorial is sponsored by Sirtex Medical, is only available in selected countries and geographies.
The SUMM90YT conference (23 February, Frankfurt, Germany)—hosted by Sirtex—gathered leading...



